NCCN Collaborates with Pfizer for New Biosimilars Research Projects in Oncology
Shots:
- NCCN collaborates with Pfizer to select ten projects to receive funding and strengthen innovations to improve the lives of people with cancer and adopt biosimilars in oncology
- NCCN committed to exploring new avenues with the availability of affordable- effective treatment options in oncology
- NCCN ORP will support preclinical- translational- clinical research- and quality improvement projects in oncology
Ref: PRNewswire | Image: Tukuz
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
